RUI: connecting threonine metabolism to chromatin silencing and genome stability
Active Project Grant Awarded Last action
- Award ID
- 2548778
- Recipient
-
CAL Poly Corporation UEI MC4RJJM9XLT5
- Awarding agency
-
Division of Molecular and Cellular Biosciences
National Science Foundation
- Obligated
- $310,099
Award facts
- Assistance listing
- 47.074 Biological Sciences
- Completion date 8% complete
- Place of performance
- San Luis Obispo, CA 93407, USA
Award details come from USAspending.gov.
About this award
The National Science Foundation Division of Molecular and Cellular Biosciences awarded CAL Poly Corporation $310,099 on August 1, 2026, to identify and characterize multifunctional proteins (moonlighters) that connect threonine metabolism to chromatin silencing and genome stability. The award funds research conducted under the Biological Sciences program (CFDA 47.074).
Undergraduate researchers will employ molecular biology and genetic techniques in Saccharomyces cerevisiae to determine how aspartate kinase (HOM3) and aspartic beta semi-aldehyde dehydrogenase (HOM2)—enzymes canonically associated with threonine biosynthesis—function in regulating ribosomal DNA silencing and epigenetic modification. The project addresses the intersection of amino acid synthesis and DNA accessibility, with potential applications to understanding aging and disease processes. Students will participate in experimental design, data interpretation, and scientific communication, with opportunities to present findings at local and national venues. Performance occurs in San Luis Obispo, California, from August 1, 2026, through July 31, 2029.
Description
- Abstract
- Traditionally, proteins have been understood to have only one primary function. However, recent research has brought attention to a new class of multi-functional proteins known as ?moonlighters.? Hundreds of moonlighters have now been characterized, revealing unexpected connections between important biological processes that were previously thought to be unrelated. This project seeks to identify and characterize new moonlighters that operate at the intersection of amino acid synthesis and DNA accessibility. Because these two pathways are essential for proper cellular function, this work has the potential to provide new insights into processes that contribute to aging and disease. The project will train undergraduate researchers in a diverse array of molecular biology and genetic techniques in the budding yeast saccharomyces cerevisiae that are relevant to biotechnology. Students will also play central roles in experimental design, data interpretation, and scientific communication and will have multiple opportunities to engage with the broader scientific community at the local and national levels. A growing class of multifunctional enzymes known as moonlighters challenges the traditional ?one protein, one function? Paradigm that has shaped our understanding of cellular pathways. In saccharomyces cerevisiae, the ribosomal DNA (rdna) is a silenced locus characterized by a delicate balance of epigenetic modifications that regulate transcriptional levels in response to cellular cues. Disruption of this silencing can significantly affect key cellular processes, including genomic stability and cellular lifespan. In this project, undergraduate researchers will employ molecular biology and genetic techniques to determine how aspartate kinase (HOM3) and aspartic beta semi-aldehyde dehydrogenase (HOM2), two enzymes canonically associated with threonine biosynthetic functions but now implicated in chromatin-based roles, contribute to rdna silencing. Crispr-based mutagenesis will be used to investigate the dependence of rdna silencing on threonine metabolic activity. Flow cytometry will be used to quantify silencing dynamics, and double-mutant and overexpression studies will shed light on functional genetic interactions with established rdna epigenetic modifiers. Because amino acid metabolism and chromatin silencing are well-conserved and ancient processes, this work may provide insight into how distinct cellular pathways evolve functional connections. Additionally, since the threonine biosynthetic pathway is absent in humans, these studies may also provide insight into biotechnological applications such as the design of antifungal therapies. The project will provide undergraduate students with genuine discovery-driven research experiences, enhance their intellectual, analytical, and technical skills, and prepare them for future careers in science and technology. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the foundation's intellectual merit and broader impacts review criteria.- subawards are not planned for this award.
Quick answers
Who received award 2548778?
2548778 was awarded to CAL Poly Corporation by Division of Molecular and Cellular Biosciences (National Science Foundation) on August 1, 2026.
How much is award 2548778 worth?
$310,099 has been obligated on 2548778.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award